MBIO insider filings
MUSTANG BIO, INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-04-27. Screen MBIO transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for MBIO between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — MUSTANG BIO, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-27 | 4 | Litchman Manuel MD — President, CEO and Interim CFO, Director | Tax withholding (F): 19 @ $0.75 | EDGAR |
| 2026-01-05 | 4 | Fortress Biotech, Inc. — 10% owner | Grant/award (A): 278,385 @ $0 | EDGAR |
| 2025-12-30 | 4 | Jin David — Director | Purchase (P): 247 @ $0.96 | EDGAR |
| 2025-12-30 | 4 | Chill Adam J. — Director | Sale (S): 4 @ $0.95 | EDGAR |
| 2025-12-30 | 4 | Herskowitz Neil — Director | Sale (S): 247 @ $0.96 | EDGAR |
| 2025-10-01 | 4 | Fortress Biotech, Inc. — 10% owner | Grant/award (A): 59,334 @ $0 | EDGAR |
| 2025-04-28 | 4 | Litchman Manuel MD — President, CEO and Interim CFO, Director | Tax withholding (F): 27 @ $1.24 | EDGAR |
| 2025-04-02 | 4 | Fortress Biotech, Inc. — 10% owner | Grant/award (A): 67,806 @ $0 | EDGAR |
| 2024-06-28 | 4 | Fortress Biotech, Inc. — 10% owner | Grant/award (A): 575,191 @ $0 | EDGAR |
| 2024-06-04 | 4 | Litchman Manuel MD — President and CEO, Director | Tax withholding (F): 1,396 @ $0.35 | EDGAR |
| 2024-06-04 | 4 | Litchman Manuel MD — President and CEO, Director | Tax withholding (F): 1,248 @ $12.15 · Tax withholding (F): 1,572 @ $4.21 | EDGAR |
| 2024-01-03 | 4 | Fortress Biotech, Inc. — 10% owner | Grant/award (A): 419,092 @ $0 | EDGAR |
| 2023-07-07 | 4 | ROSENWALD LINDSAY A MD — Director | Grant/award (A): 7,246 @ $0 | EDGAR |
| 2023-07-07 | 4 | Litchman Manuel MD — President and CEO, Director | Grant/award (A): 5,000 @ $0 | EDGAR |
| 2023-07-07 | 4 | Chill Adam J. — Director | Grant/award (A): 7,246 @ $0 | EDGAR |
| 2023-07-07 | 4 | Herskowitz Neil — Director | Grant/award (A): 7,246 @ $0 | EDGAR |
| 2023-07-07 | 4 | ZELEFSKY MICHAEL J — Director | Grant/award (A): 7,246 @ $0 | EDGAR |
| 2023-07-07 | 4 | WEISS MICHAEL S — Director | Grant/award (A): 7,246 @ $0 | EDGAR |
| 2023-04-03 | 4 | Litchman Manuel MD — Director | Purchase (P): 5,000 @ $0.74 · Grant/award (A): 61,000 @ $0 · Purchase (P): 5,000 @ $0.52 | EDGAR |
| 2023-04-03 | 4 | ROSENWALD LINDSAY A MD — Director | Purchase (P): 4,094 @ $0.74 · Grant/award (A): 71,664 @ $0 · Purchase (P): 5,000 @ $0.52 | EDGAR |
| 2023-04-03 | 4 | Chill Adam J. — Director | Grant/award (A): 71,664 @ $0 | EDGAR |
| 2023-04-03 | 4 | Herskowitz Neil — Director | Grant/award (A): 71,664 @ $0 | EDGAR |
| 2023-04-03 | 4 | ZELEFSKY MICHAEL J — Director | Grant/award (A): 71,664 @ $0 | EDGAR |
| 2023-04-03 | 4 | WEISS MICHAEL S — Director | Grant/award (A): 71,664 @ $0 | EDGAR |
| 2023-01-06 | 4 | Fortress Biotech, Inc. — 10% owner | Grant/award (A): 2,807,008 @ $0 | EDGAR |
| 2021-12-16 | 4 | Achenbach Brian — SVP, Fin. & Corp. Controller | Grant/award (A): 22,500 @ $0 · Sale (S): 4,374 @ $1.83 | EDGAR |
| 2021-11-08 | 4 | Litchman Manuel MD — President and CEO, Director | Purchase (P): 65,000 @ $2.24 | EDGAR |
| 2021-10-21 | 4 | Achenbach Brian — SVP, Fin. & Corp. Controller | Sale (S): 4,450 @ $2.28 | EDGAR |
| 2021-09-24 | 4 | ROSENWALD LINDSAY A MD — Director | Grant/award (A): 1,170 @ $2.58 | EDGAR |
| 2021-09-24 | 4 | Litchman Manuel MD — President and CEO, Director | Grant/award (A): 2,746 @ $2.58 | EDGAR |
| 2021-08-05 | 4 | Litchman Manuel MD — President and CEO, Director | Purchase (P): 86,206 @ $2.91 | EDGAR |
| 2021-07-08 | 4 | ROSENWALD LINDSAY A MD — Director | Grant/award (A): 13,774 @ $0 | EDGAR |
| 2021-07-08 | 4 | Litchman Manuel MD — President and CEO, Director | Grant/award (A): 61,000 @ $0 | EDGAR |
| 2021-07-08 | 4 | Chill Adam J. — Director | Grant/award (A): 13,774 @ $0 | EDGAR |
| 2021-07-08 | 4 | Herskowitz Neil — Director | Grant/award (A): 13,774 @ $0 | EDGAR |
| 2021-07-08 | 4 | ZELEFSKY MICHAEL J — Director | Grant/award (A): 13,774 @ $0 | EDGAR |
| 2021-07-08 | 4 | WEISS MICHAEL S — Director | Grant/award (A): 13,774 @ $0 | EDGAR |
| 2021-04-29 | 4 | Litchman Manuel MD — President and CEO, Director | Sale (S): 4,025 @ $3.04 · Sale (S): 8,348 @ $3.04 | EDGAR |
| 2021-04-16 | 4 | Achenbach Brian — SVP, Fin. & Corp. Controller | Sale (S): 6,144 @ $3.69 · Sale (S): 3,033 @ $2.64 · Sale (S): 880 @ $3.04 · Sale (S): 3,056 @ $2.97 · Sale (S): 5,185 @ $3.03 · Sale (S): 2,423 @ $3.36 | EDGAR |
| 2021-03-15 | 4 | Litchman Manuel MD — President and CEO, Director | Grant/award (A): 5,000 @ $2.83 · Purchase (P): 165,562 @ $3.12 | EDGAR |
| 2021-03-15 | 4 | ROSENWALD LINDSAY A MD — Director | Grant/award (A): 1,043 @ $2.83 | EDGAR |
| 2021-03-15 | 4 | Achenbach Brian — SVP, Fin. & Corp. Controller | Grant/award (A): 22,500 @ $0 | EDGAR |
| 2020-12-22 | 4 | Litchman Manuel MD — President and CEO, Director | Grant/award (A): 5,000 @ $2.48 · Grant/award (A): 61,000 @ $0 · Purchase (P): 100,000 @ $2.91 | EDGAR |
| 2020-12-22 | 4/A | ROSENWALD LINDSAY A MD — Director | Grant/award (A): 1,182 @ $2.48 · Purchase (P): 100,000 @ $2.66 | EDGAR |
| 2020-12-22 | 4/A | ROSENWALD LINDSAY A MD — Director | Grant/award (A): 831 @ $2.48 · Grant/award (A): 16,611 @ $2.48 | EDGAR |
| 2020-12-15 | 4 | ROSENWALD LINDSAY A MD — Director | Purchase (P): 100,000 @ $2.66 | EDGAR |
| 2020-08-19 | 4 | Chill Adam J. — Director | Grant/award (A): 16,611 @ $0 | EDGAR |
| 2020-08-19 | 4 | Herskowitz Neil — Director | Grant/award (A): 16,611 @ $0 | EDGAR |
| 2020-08-19 | 4 | ZELEFSKY MICHAEL J — Director | Grant/award (A): 16,611 @ $0 | EDGAR |
| 2020-08-19 | 4 | WEISS MICHAEL S — Director | Grant/award (A): 16,611 @ $0 | EDGAR |
Recent 8-K events — MUSTANG BIO, INC.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-10-15 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-04-17 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2025-12-23 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-09 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-05 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-02-27 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-02-21 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-02-13 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement | EDGAR |
| 2025-02-11 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-01-17 | 8-K | 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=MBIO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs